Latest from Christopher Rowland
Certain drugs purchased for pandemics and national security threats would be required to be manufactured in the United States under the president’s executive order.
  • Aug 6, 2020
  • Post Reports
The GOP battles over a trillion-dollar stimulus deal. Ahead of the November election, President Trump guts a landmark environmental law. And, how to avoid a devastating potential kink in the vaccine supply chain.
  • Jul 22, 2020
Advocacy groups and Democratic senators have complained that Moncef Slaoui's extensive financial interests in drug companies pose a conflict of interest.
  • Jul 14, 2020
Glass vials for vaccine are in demand as governments and drug companies rush to lock down supply
  • Jul 13, 2020
The company, which produces vaccines through genetic engineering, is conducting a Phase 1 safety trial in Australia of an experimental vaccine.
  • Jul 7, 2020
Moderna’s top leaders sold company stock as the share value skyrocketed.
  • Jul 2, 2020
In its race to control covid-19, the federal government is spending billions in agreements with pharmaceutical companies to subsidize development of medicines. But it is employing a looser standard of federal contracting that avoids some rules that protect taxpayer investments, said Knowledge Ecology International.
  • Jul 1, 2020
The antiviral was shown to shorten recovery times for hospitalized coronavirus patients in clinical trials.
  • Jun 29, 2020
The eventful path of Emory University’s coronavirus pill EIDD-2801 highlights financial speculation focused on drugs developed with public investment.
  • Jun 25, 2020
Critics say the government deserves more credit for tens of millions in public money spent to develop the coronavirus treatment.
  • May 26, 2020